Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
28 Sept 2026, 5:00 pmDue tomorrow
Published by the portal on this tender, for queries and grievance redressal.
DRUGS AND PHARMCEUTICALS PRODUCTS
9844151
GEM/2026/B/7994141
Two Packet Bid
PRODUCT1,PRODUCT2,PRODUCT3,PRODUCT4,PRODUCT5,PRODUCT6,PRODUCT7,PRODUCT8,PRODUCT9,PRODUCT10,PRODUCT1
Amritsar, Punjab
Total value wise evaluation
BOQ
6 documents required · 6 mandatory
3 yrs
₹50,000
₹1 L
20%
Exempted
Yes
17 Sept 2026
17 Sept 2026
29 Sept 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | PRODUCT1 | TAB APIXABAN 2.5MG | 200 | Number | Amritsar | 15 |
| 2 | PRODUCT2 | TAB BISOPROLOL 2.5MG | 200 | Number | Amritsar | 15 |
| 3 | PRODUCT3 | TAB CARVEDILOL 3.125MG | 400 | Number | Amritsar | 15 |
| 4 | PRODUCT4 | TAB CLOBAZAM 5MG | 100 | Number | Amritsar | 15 |
| 5 | PRODUCT5 | TAB DILTIAZEM SR 90MG | 100 | Number | Amritsar | 15 |
| 6 | PRODUCT6 | TAB ASPIRIN 75 MG | 800 | Number | Amritsar | 15 |
| 7 | PRODUCT7 | TAB ENALAPRIL 5MG | 400 | Number | Amritsar | 15 |
| 8 | PRODUCT8 | TAB FEBUXOSTAT 40MG | 100 | Number | Amritsar | 15 |
| 9 | PRODUCT9 | TAB METFORMIN SR 500 MG | 1,000 | Number | Amritsar | 15 |
| 10 | PRODUCT10 | TAB METHYLCOBALAMIN 1500 MG | 600 | Number | Amritsar | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9844151.pdf
GEM_BID • 0.32 MB
list_of_medicine_45_2026-09-03-16-25-49_c09c8a7d63dc3c84bc05165ecd13b467.pdf
BOQ • 0.21 MB
boq_230su_2026-09-03-16-25-49_6d09f9febd06b9f4467c3feedcb4078d.csv
BOQ • 0.00 MB
GEM_OTHER • 1.10 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .